...[W]e can marry quarantine with technology using polymerase chain reaction, or PCR. At a cost of $60 to $200 the test looks for viral particles in the blood and amplifies them millions of folds, picking up most cases of Ebola patients who may still be asymptomatic. While not 100 percent foolproof, the PCR test increases the level of certainty in determining if a patient has an Ebola infection, which can ultimately lead to a more accurate decision...Read "Rethinking the 21-Day Quarantine for Ebola Contacts" in its entirety HERE. There is more information in the article than the above excerpt, including the following:
...[A] recent article in the New England Journal of Medicine detailing the first nine months of the 2014 epidemic in West Africa raises concern about the short, often-mentioned 21 post-exposure-day periods in the guidelines. In the journal's study of 4,507 probable and confirmed cases, "approximately 95 percent of the case patients had symptom onset within 21 days of exposure." If we do the math, this means that approximately 5 percent or 225 of the Ebola cases in West Africa had symptoms 21 days after exposure, as reported by the patient or caregiver....Additional reading: Ebola Protection Guidelines On CDC Website Riddled With Mistakes.
[My unrelated-to-Ebola post today at Infidel Bloggers Alliance: How To Lose A War]